Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Paxton, JW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 24 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zhou, SF; Paxton, JW; Tingle, MD; Kestell, P
      Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    2. Zhou, SF; Paxton, JW; Tingle, MD; Kestell, P
      Determination of unbound concentration of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in human plasma by ultrafiltration followed by high-performance liquid chromatography with fluorimetric detection

      JOURNAL OF CHROMATOGRAPHY B
    3. Zhou, SF; Kestell, P; Tingle, MD; Ching, LM; Paxton, JW
      A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    4. Zhou, S; Paxton, JW; Kestell, P; Tingle, MD; Ching, LM
      In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. Zhou, SF; Chin, R; Kestell, P; Tingle, MD; Paxton, JW
      Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    6. Zhou, SF; Paxton, JW; Tingle, ID; Kestell, P; Jameson, MB; Thompson, PI; Baguley, BC
      Identification and reactivity of the major metabolite (beta-1-glucuronide)of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans

      XENOBIOTICA
    7. Zhou, SF; Paxton, JW; Kestell, P; Tingle, MD
      Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    8. Kestell, P; Zhao, LL; Baguley, BC; Palmer, BD; Muller, G; Paxton, JW; Ching, LM
      Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Zhou, SF; Paxton, JW; Tingle, MD; Kestell, P
      Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid

      DRUG METABOLISM AND DISPOSITION
    10. Collier, AC; Tingle, MD; Keelan, JA; Paxton, JW; Mitchell, MD
      A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines

      DRUG METABOLISM AND DISPOSITION
    11. Schofield, PC; Robertson, IGC; Paxton, JW
      Inter-species variation in the metabolism and inhibition of N-[(2 '-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase

      BIOCHEMICAL PHARMACOLOGY
    12. Zhou, SF; Paxton, JW; Tingle, MD; McCall, J; Kestell, P
      Determination of two major metabolites of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in hepatic microsomal incubations by high-performance liquid chromatography with fluorescence detection

      JOURNAL OF CHROMATOGRAPHY B
    13. Kestell, P; Dunlop, IC; McCrystal, MR; Evans, BD; Paxton, JW; Gamage, RSKA; Baguley, BC
      Plasma pharmacokinetics of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    14. Schofield, PC; Robertson, IGC; Paxton, JW; McCrystal, MR; Evans, BD; Kestell, P; Baguley, BC
      Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    15. Kestell, P; Paxton, JW; Rewcastle, GW; Dunlop, I; Baguley, BC
      Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat acid rabbit

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    16. Galettis, P; Carr, JL; Paxton, JW; McKeage, MJ
      Quantitative determination of platinum complexes in human plasma generatedfrom the oral antitumour drug JM216 using directly coupled high-performance liquid chromatography-inductively coupled plasma mass spectrometry without desolvation

      JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
    17. PAXTON JW
      THE ALLOMETRIC APPROACH FOR INTERSPECIES SCALING OF PHARMACOKINETICS AND TOXICITY OF ANTICANCER DRUGS

      Clinical and experimental pharmacology and physiology
    18. EVANS SMH; ROBERTSON IGC; PAXTON JW
      PLASMA-PROTEIN BINDING OF THE EXPERIMENTAL ANTITUMOR AGENT ACRIDINE-4-CARBOXAMIDE IN MAN, DOG, RAT AND RABBIT

      Journal of Pharmacy and Pharmacology
    19. AMAN MG; WERRY JS; PAXTON JW; TURBOTT SH
      EFFECTS OF PHENYTOIN ON COGNITIVE-MOTOR PERFORMANCE IN CHILDREN AS A FUNCTION OF DRUG CONCENTRATION, SEIZURE TYPE, AND TIME OF MEDICATION

      Epilepsia
    20. CORNFORD EM; YOUNG D; PAXTON JW; HYMAN S; FARRELL CL; ELLIOTT RB
      BLOOD-BRAIN GLUCOSE TRANSFER IN THE MOUSE

      Neurochemical research
    21. PAXTON JW; YOUNG D; EVANS SMH; ROBERTSON IGC; KESTELL P
      TUMOR PROFILE OF N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE AFTER INTRAPERITONEAL ADMINISTRATION IN THE MOUSE

      Cancer chemotherapy and pharmacology
    22. PAXTON JW; YOUNG D; ROBERTSON IGG
      PHARMACOKINETICS OF ACRIDINE-4-CARBOXAMIDE IN THE RAT, WITH EXTRAPOLATION TO HUMANS

      Cancer chemotherapy and pharmacology
    23. ROBERTSON IGC; PALMER BD; PAXTON JW; BLAND TJ
      METABOLISM OF THE EXPERIMENTAL ANTITUMOR AGENT ACRIDINE CARBOXAMIDE IN THE MOUSE

      Drug metabolism and disposition
    24. SCHLEMPER B; SIEGERS DJ; PAXTON JW; ROBERTSON IGC
      RAT HEPATOCYTE-MEDIATED METABOLISM OF THE EXPERIMENTAL ANTITUMOR AGENT N-[2'-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE

      Xenobiotica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 05:19:54